Rocket Pharmaceuticals Price Target Raised to $30.00 at Cantor Fitzgerald (RCKT)
Tweet Send to a Friend
Cantor Fitzgerald Josh Schimmer reiterates Overweight rating on Rocket Pharmaceuticals (NASDAQ: RCKT) and raises price target to $30.00 (from $20.00).The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
